Repeat Local Treatment of Recurrent Colorectal Liver Metastases, the Role of Neoadjuvant Chemotherapy: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study.
colorectal liver metastases (CRLM)
microwave ablation (MWA)
neoadjuvant chemotherapy (NAC)
partial hepatectomy (PH)
radiofrequency ablation (RFA)
repeat local treatment
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
05 Oct 2021
05 Oct 2021
Historique:
received:
02
08
2021
revised:
02
10
2021
accepted:
03
10
2021
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
14
10
2021
Statut:
epublish
Résumé
This cohort study aimed to evaluate efficacy, safety, and survival outcomes of neoadjuvant chemotherapy (NAC) followed by repeat local treatment compared to upfront repeat local treatment of recurrent colorectal liver metastases (CRLM). A total of 152 patients with 267 tumors from the prospective Amsterdam Colorectal Liver Met Registry (AmCORE) met the inclusion criteria. Two cohorts of patients with recurrent CRLM were compared: patients who received chemotherapy prior to repeat local treatment (32 patients) versus upfront repeat local treatment (120 patients). Data from May 2002 to December 2020 were collected. Results on the primary endpoint overall survival (OS) and secondary endpoints local tumor progression-free survival (LTPFS) and distant progression-free survival (DPFS) were reviewed using the Kaplan-Meier method. Subsequently, uni- and multivariable Cox proportional hazard regression models, accounting for potential confounders, were estimated. Additionally, subgroup analyses, according to patient, initial and repeat local treatment characteristics, were conducted. Procedure-related complications and length of hospital stay were compared using chi-square test and Fisher's exact test. The 1-, 3-, and 5-year OS from date of diagnosis of recurrent disease was 98.6%, 72.5%, and 47.7% for both cohorts combined. The crude survival analysis did not reveal a significant difference in OS between the two cohorts (
Identifiants
pubmed: 34638481
pii: cancers13194997
doi: 10.3390/cancers13194997
pmc: PMC8507904
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cardiovasc Intervent Radiol. 2018 Aug;41(8):1189-1204
pubmed: 29666906
Ann Surg. 2007 Aug;246(2):295-300
pubmed: 17667509
Ann Surg. 2002 Jun;235(6):863-71
pubmed: 12035044
Int J Hyperthermia. 2018 Sep;34(6):853-862
pubmed: 28826279
J Surg Oncol. 2006 Jan 1;93(1):1-7
pubmed: 16353192
J Vasc Interv Radiol. 2011 Jun;22(6):755-61
pubmed: 21514841
Cardiovasc Intervent Radiol. 2010 Feb;33(1):11-7
pubmed: 19924474
Can Assoc Radiol J. 2018 Feb;69(1):51-62
pubmed: 29458955
Ann Surg. 2013 Oct;258(4):619-26; discussion 626-7
pubmed: 24018645
Cancers (Basel). 2021 Jun 02;13(11):
pubmed: 34199556
Br J Surg. 2013 May;100(6):808-18
pubmed: 23494765
Ann Transl Med. 2020 Nov;8(21):1448
pubmed: 33313193
Ann Surg. 2003 Dec;238(6):871-83; discussion 883-4
pubmed: 14631224
J Gastrointest Surg. 2018 Oct;22(10):1752-1763
pubmed: 29948554
Clin Colorectal Cancer. 2021 Jun;20(2):e82-e95
pubmed: 33246789
Lancet Oncol. 2013 Nov;14(12):1208-15
pubmed: 24120480
BMC Cancer. 2018 Jan 15;18(1):78
pubmed: 29334918
J Clin Oncol. 2007 Oct 10;25(29):4575-80
pubmed: 17925551
Ann Surg Oncol. 2014 Apr;21(4):1276-86
pubmed: 24346766
Ann Surg Oncol. 2020 Apr;27(4):1164-1173
pubmed: 31720935
Ann Surg Oncol. 2019 Jun;26(6):1833-1840
pubmed: 30830537
Lancet. 1994 Jun 4;343(8910):1405-10
pubmed: 7515134
Radiology. 2016 Sep;280(3):949-59
pubmed: 27010254
Br J Surg. 2015 Sep;102(10):1175-83
pubmed: 26206254
Cardiovasc Intervent Radiol. 2013 Feb;36(1):166-75
pubmed: 22535243
Int J Surg. 2016 Dec;36(Pt A):96-103
pubmed: 27741421
Ann Surg Oncol. 2008 Sep;15(9):2458-64
pubmed: 18463927
Surgery. 2018 Jun;163(6):1238-1244
pubmed: 29455841
World J Surg. 2012 Sep;36(9):2171-8
pubmed: 22547015
Tech Vasc Interv Radiol. 2020 Jun;23(2):100672
pubmed: 32591188
Ann Surg. 2018 Mar;267(3):514-520
pubmed: 28002060
J Clin Oncol. 2008 Apr 1;26(10):1635-41
pubmed: 18375892
Biomedicines. 2021 Aug 05;9(8):
pubmed: 34440165
Br J Surg. 1990 Nov;77(11):1241-6
pubmed: 2253003
Ann Surg. 2019 Feb;269(2):322-330
pubmed: 28820745
J Natl Compr Canc Netw. 2021 Mar 02;19(3):329-359
pubmed: 33724754
Ann Surg Oncol. 2006 Dec;13(12):1579-87
pubmed: 17003958
Dis Colon Rectum. 2009 Mar;52(3):475-83
pubmed: 19333049
Ann Surg. 2004 Jun;239(6):818-25; discussion 825-7
pubmed: 15166961
PLoS One. 2014 Jan 21;9(1):e86543
pubmed: 24466143
BMC Cancer. 2018 Aug 15;18(1):821
pubmed: 30111304
J Vasc Interv Radiol. 2015 Apr;26(4):583-7.e1
pubmed: 25805540
BMC Cancer. 2014 Nov 04;14:810
pubmed: 25369977
Cardiovasc Intervent Radiol. 2010 Apr;33(2):297-306
pubmed: 19688366
Radiology. 2012 Dec;265(3):958-68
pubmed: 23091175
Radiology. 2016 Feb;278(2):601-11
pubmed: 26267832
Ann Surg. 2004 Oct;240(4):644-57; discussion 657-8
pubmed: 15383792
Updates Surg. 2021 Aug;73(4):1349-1358
pubmed: 33844146
Int J Colorectal Dis. 2013 Aug;28(8):1135-41
pubmed: 23468250
J Gastrointest Surg. 2003 Jan;7(1):109-117
pubmed: 12559192
Int J Colorectal Dis. 2013 Jul;28(7):1009-17
pubmed: 23371333
Eur Radiol. 2018 Jul;28(7):2727-2734
pubmed: 29417253
Ann Surg Oncol. 2012 Dec;19(13):4262-9
pubmed: 22752375
World J Surg Oncol. 2011 Nov 24;9:154
pubmed: 22115124
Br J Surg. 2017 May;104(6):760-768
pubmed: 28240361
Oncotarget. 2017 Aug 2;8(39):66117-66127
pubmed: 29029497
Eur Radiol. 2015 Dec;25(12):3438-54
pubmed: 25994193
Br J Surg. 2012 Sep;99(9):1278-83
pubmed: 22864889
Eur J Surg Oncol. 2015 Jul;41(7):859-67
pubmed: 25979624
Ann Surg Oncol. 2009 Sep;16(9):2385-90
pubmed: 19554377
Int J Clin Oncol. 2018 Oct;23(5):908-916
pubmed: 29619592
J Gastrointest Surg. 2003 Dec;7(8):1034-44
pubmed: 14675713
World J Surg Oncol. 2019 Feb 15;17(1):33
pubmed: 30770753
J Gastrointest Surg. 2020 Feb;24(2):380-387
pubmed: 30830515
J Clin Oncol. 2011 May 20;29(15):2011-9
pubmed: 21502544
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
World J Surg. 2018 Aug;42(8):2651-2659
pubmed: 29423737
Cancer Med. 2017 Feb;6(2):331-338
pubmed: 28101946
Ann Surg. 1984 May;199(5):502-8
pubmed: 6721600
Radiology. 2014 Oct;273(1):241-60
pubmed: 24927329
JAMA Oncol. 2016 May 1;2(5):643-653
pubmed: 26768652
Ann Surg. 1997 Jan;225(1):51-60; discussion 60-2
pubmed: 8998120
Eur Radiol. 2021 Sep;31(9):6489-6499
pubmed: 33447860
Cancers (Basel). 2020 Jul 03;12(7):
pubmed: 32635230
J Vasc Interv Radiol. 2018 Feb;29(2):268-275.e1
pubmed: 29203394
Cancers (Basel). 2021 Aug 26;13(17):
pubmed: 34503113
Oncotarget. 2016 Apr 12;7(15):21034-45
pubmed: 26992234
Dig Surg. 2019;36(3):233-240
pubmed: 29597209
Eur Radiol. 2019 May;29(5):2698-2705
pubmed: 30402706
Int J Hyperthermia. 2019;36(1):337-343
pubmed: 30729818
J Clin Oncol. 2006 May 1;24(13):2065-72
pubmed: 16648507
Ann Surg Oncol. 2016 Aug;23(8):2635-43
pubmed: 27016292
Br J Surg. 2011 Apr;98(4):565-71; discussion 571-2
pubmed: 21656721
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28376151
Cancers (Basel). 2021 Jan 20;13(3):
pubmed: 33561088
Br J Surg. 2003 Aug;90(8):963-9
pubmed: 12905549
HPB (Oxford). 2011 Nov;13(11):774-82
pubmed: 21999590
Radiology. 2021 May;299(2):470-480
pubmed: 33724066
J Vasc Interv Radiol. 2018 Mar;29(3):395-403.e1
pubmed: 29395898
Arch Surg. 2008 Dec;143(12):1204-12
pubmed: 19075173
Eur J Cancer. 2007 Sep;43(14):2037-45
pubmed: 17766104
Radiology. 2021 Jan;298(1):212-218
pubmed: 33170105